NZ337505A
(en)
|
1997-02-11 |
2001-07-27 |
Univ College Cork Nat Univ Ie |
Isolated antimicrobial agents from Lactobacillus salivarius
|
IT1299070B1
(it)
*
|
1998-04-10 |
2000-02-07 |
Proge Farm Srl |
Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
SE523136C2
(sv)
*
|
1999-12-21 |
2004-03-30 |
Gottfriesmottagningen Ab |
Användning av stafylokockbakterier i samband med behandling av irritable bowelsyndrome
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
GB0127916D0
(en)
*
|
2001-11-21 |
2002-01-16 |
Rowett Res Inst |
Method
|
AUPS088702A0
(en)
|
2002-03-04 |
2002-03-28 |
Borody, Thomas Julius |
Electrolyte purgative
|
US8894991B2
(en)
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
US20050152884A1
(en)
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
AR052472A1
(es)
|
2005-05-31 |
2007-03-21 |
Iams Company |
Lactobacilos probioticos para felinos
|
WO2006130188A1
(en)
|
2005-05-31 |
2006-12-07 |
The Iams Company |
Feline probiotic bifidobacteria
|
PL1920781T3
(pl)
|
2006-11-10 |
2015-06-30 |
Glycotope Gmbh |
Kompozycje zawierające core-1-dodatnie mikroorganizmy i ich zastosowanie w leczeniu lub profilaktyce nowotworów
|
CN101711158A
(zh)
|
2007-02-01 |
2010-05-19 |
爱默思公司 |
使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
|
EP2211879B1
(de)
|
2007-10-26 |
2014-05-07 |
Brenda E. Moore |
Probiotische zusammensetzungen und verfahren zur einleitung und unterstützung von gewichtsverlust
|
CN102940652B
(zh)
*
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
GB0916335D0
(en)
*
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
WO2011094027A1
(en)
|
2010-02-01 |
2011-08-04 |
Hlavka Edwin J |
Bacteriotherapy for clostridium difficile colitis
|
CA2807242C
(en)
|
2010-08-04 |
2017-05-02 |
Thomas Julius Borody |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
CA2821196C
(en)
|
2010-12-13 |
2022-11-22 |
Thomas Julius Borody |
Gastric and colonic formulations and methods for making and using them
|
BR112013022927A2
(pt)
|
2011-03-09 |
2016-12-06 |
Univ Minnesota |
composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
CN104780932A
(zh)
|
2012-02-29 |
2015-07-15 |
伊西康内外科公司 |
微生物区系的组合物及与其相关的方法
|
US9719144B2
(en)
|
2012-05-25 |
2017-08-01 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
ES2717282T3
(es)
|
2012-07-27 |
2019-06-20 |
Redhill Biopharma Ltd |
Formulaciones y métodos para fabricar formulaciones para su uso en la evacuación colónica
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
US11179427B2
(en)
|
2013-01-21 |
2021-11-23 |
Eth Zurich |
Baby food composition comprising viable propionic acid-producing bacteria
|
WO2014121304A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Health, Inc. |
Compositions and methods
|
CA2899925A1
(en)
|
2013-02-04 |
2014-08-07 |
Seres Therapeutics, Inc. |
Compositions and methods for inhibition of pathogenic bacterial growth
|
CA2906921A1
(en)
|
2013-03-15 |
2014-09-18 |
Seres Therapeutics, Inc. |
Network-based microbial compositions and methods
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
US9511100B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US10383901B2
(en)
|
2013-06-05 |
2019-08-20 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9782445B2
(en)
|
2013-06-05 |
2017-10-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
US9694039B2
(en)
|
2013-06-05 |
2017-07-04 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
CN105473152A
(zh)
|
2013-06-05 |
2016-04-06 |
雷柏奥提斯有限公司 |
菌群恢复疗法(mrt)、组合物和制造方法
|
CN116370507A
(zh)
|
2013-11-25 |
2023-07-04 |
赛里斯治疗公司 |
协同细菌组合物以及其制造方法和用途
|
EP3082431A4
(de)
|
2013-12-16 |
2017-11-15 |
Seres Therapeutics, Inc. |
Bakterielle zusammensetzungen und verfahren zur verwendung davon zur behandlung von immunsystemkrankheiten
|
CN106573044B
(zh)
*
|
2014-08-05 |
2020-01-21 |
深圳华大基因科技有限公司 |
真杆菌属在预防和治疗结直肠癌相关疾病中的用途
|
CN106687130B
(zh)
*
|
2014-08-05 |
2020-01-21 |
深圳华大基因科技有限公司 |
真杆菌属在预防和治疗结直肠癌相关疾病中的用途
|
CN104546951B
(zh)
*
|
2014-09-30 |
2019-03-01 |
深圳华大基因科技有限公司 |
规则粪球菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
JP6868562B2
(ja)
|
2014-10-31 |
2021-05-19 |
ペンデュラム セラピューティクス, インコーポレイテッド |
障害の微生物的処置および診断に関する方法および組成物
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
GB201421735D0
(en)
*
|
2014-12-07 |
2015-01-21 |
Craig Nicola M |
Humanized gut microbiota
|
MX2017008449A
(es)
|
2014-12-23 |
2017-10-12 |
4D Pharma Res Ltd |
Polipeptido de pirina y modulacion inmune.
|
PT3065748T
(pt)
|
2014-12-23 |
2018-02-28 |
4D Pharma Res Ltd |
Uma estirpe de bacteroides thetaiotaomicron e o seu uso na redução da inflamação
|
EP3294308A4
(de)
|
2015-05-14 |
2019-03-06 |
University of Puerto Rico |
Verfahren zur wiederherstellung der biozönose von neugeborenen
|
WO2016183577A1
(en)
|
2015-05-14 |
2016-11-17 |
Crestovo Llc |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
CN108243608A
(zh)
|
2015-05-22 |
2018-07-03 |
亚利桑那大学董事会 |
用于治疗自闭症谱系障碍及相关症状的方法
|
US10905726B2
(en)
|
2015-06-09 |
2021-02-02 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
KR102066242B1
(ko)
|
2015-06-09 |
2020-01-14 |
리바이오틱스, 인코퍼레이티드 |
미생물상 복원 치료(mrt) 조성물 및 제조 방법
|
US10799539B2
(en)
|
2015-06-09 |
2020-10-13 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
US10828340B2
(en)
|
2015-06-09 |
2020-11-10 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT) compositions and methods of manufacture
|
LT3360559T
(lt)
|
2015-06-15 |
2019-12-27 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterijų kamienus
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
SI3240554T1
(sl)
|
2015-06-15 |
2019-12-31 |
4D Pharma Research Limited, |
Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
TWI733676B
(zh)
|
2015-06-15 |
2021-07-21 |
英商4D製藥研究有限公司 |
包含細菌菌株之組合物
|
BR112018010089A2
(pt)
|
2015-11-20 |
2018-11-13 |
4D Pharma Res Ltd |
composições compreendendo cepas bacterianas
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
US11564667B2
(en)
|
2015-12-28 |
2023-01-31 |
New York University |
Device and method of restoring microbiota of newborns
|
SG11201807195VA
(en)
|
2016-03-04 |
2018-09-27 |
4D Pharma Plc |
Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
WO2018071536A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating primary sclerosing cholangitis and related disorders
|
US11026978B2
(en)
|
2016-10-11 |
2021-06-08 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
EP3606541A1
(de)
|
2017-04-05 |
2020-02-12 |
Crestovo Holdings LLC |
Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit (pd) und verwandten erkrankungen
|
US11040073B2
(en)
|
2017-04-05 |
2021-06-22 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
PT3630136T
(pt)
|
2017-05-22 |
2021-06-11 |
4D Pharma Res Ltd |
Composições que compreendem estirpes bacterianas
|
MA41708A
(fr)
|
2017-05-24 |
2020-04-08 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
CA3064773A1
(en)
|
2017-05-26 |
2018-11-29 |
Crestovo Holdings Llc |
Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
|
LT3638271T
(lt)
|
2017-06-14 |
2021-01-11 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterines padermes
|
RS60910B1
(sr)
|
2017-06-14 |
2020-11-30 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijski soj roda megasphaera i njihove upotrebe
|
RU2659417C1
(ru)
*
|
2017-06-22 |
2018-07-02 |
Федеральное государственное бюджетное научное учреждение "Иркутский научный центр хирургии и травматологии" |
Устройство для подготовки донорского фекального материала к трансплантации
|
EP3664823A4
(de)
|
2017-08-07 |
2021-05-12 |
Finch Therapeutics, Inc. |
Zusammensetzungen und verfahren zur aufrechterhaltung und wiederherstellung einer gesunden darmbarriere
|
CA3072206A1
(en)
|
2017-08-14 |
2019-02-21 |
Seres Therapeutics, Inc. |
Compositions and methods for treating cholestatic disease
|
JP2020532515A
(ja)
|
2017-08-30 |
2020-11-12 |
ペンデュラム セラピューティクス, インコーポレイテッド |
マイクロバイオーム関連障害の処置のための方法および組成物
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
KR20200021257A
(ko)
*
|
2018-08-20 |
2020-02-28 |
아주대학교산학협력단 |
유박테리움 렉탈레를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물
|
AU2019351017A1
(en)
|
2018-09-27 |
2021-04-29 |
Finch Therapeutics Holdings Llc. |
Compositions and methods for treating epilepsy and related disorders
|